Colin Hill's most recent trade in Fulcrum Therapeutics Inc was a trade of 36,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Colin Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Colin Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) |